Cancerbackup: Monoclonal antibodies

Skip the page content navigation if you do not require links to content sections within this page.

Page Content Navigation

Skip the main banner if you do not want to read it as the next section.


Page Banner

Want to speak to a specialist cancer nurse? Call free on 0808 800 1234



The best cancer information for everyone.
Cancerbackup has merged with Macmillan. Together we can provide a wealth of high quality information about cancer.


Skip the main content if you do not want to read it as the next section.


Monoclonal antibodies


One of the ways we fight infection is to make antibodies. They help our immune system to recognise an infection if we are exposed to it again and to enable our body to deal with it quickly. Antibodies can be made in a laboratory and used to treat cancer.

Monoclonal antibodies (called this because they come from a single cell) work by recognising the protein on the surface of the cancer cell and then locking onto it (like a key in a lock). They destroy the cancer by either:

  • triggering the body’s immune system to attack the cancer cell and can cause the cell to kill itself or
  • attaching a cancer drug or a radioactive substance to the antibody which delivers them directly to the cancer cell because they target those specific cells (targeted therapy).

Content last reviewed: 01 April 2008
Page last modified: 14 January 2009

Get support

Look for other people in the same situation on our What Now? community - read their blogs or talk to them in our chat rooms.

Find out about other ways to get support on the main Macmillan website.